| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/28/2009 | EP1861497A4 Protein and its use in diagnosing alzheimer's disease |
| 01/28/2009 | CN101356187A Oxidation process for the preparation of n-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-{N-[(tert-butylamino)carbonyl]-3-methyl-l-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide and re |
| 01/28/2009 | CN101356186A Prion-specific peptoid reagents |
| 01/28/2009 | CN100455592C Method for extracting glutathione from glutathione fermented broth |
| 01/27/2009 | US7482448 Compounds and compositions as cathepsin inhibitors |
| 01/27/2009 | US7482427 Synthetic peptides having a non growth factor heparin binding region, a linker, and sequences; treatment of bone lesions, degenerative joint disease and to enhance bone formation |
| 01/27/2009 | US7482426 C23 Polypeptides |
| 01/27/2009 | US7482379 protease inhibitors more specifically to peptide inhibitors of cysteine proteases; viral infections, stroke, neurodegenerative disease, inflammatory diseases,autoimmune diseases like lupus, cancer; alpha aza-amino acid residues; prevent proteolysis |
| 01/27/2009 | US7482018 Using hydrophilic surfactant; encapsulated hydrophobic drug |
| 01/27/2009 | CA2415442C Novel .beta. crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same |
| 01/22/2009 | WO2009010804A1 Macrocyclic compounds as antiviral agents |
| 01/22/2009 | WO2009010733A2 Peptide gap junction modulators |
| 01/22/2009 | US20090023760 anticarcinogenic agent; thymidylate synthase (TS) inhibitors; Tri-tert-butyl N-{N-{4-[N-((6RS)-2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclopenta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamate |
| 01/22/2009 | US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections |
| 01/22/2009 | US20090023648 Methods for Treating Body Tissue |
| 01/22/2009 | US20090022724 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 01/22/2009 | US20090022674 Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by uv radiation |
| 01/22/2009 | US20090022623 Peptides Capable of Functioning as Mimotopes for Hormonal Analytes |
| 01/22/2009 | CA2699891A1 Macrocyclic compounds as antiviral agents |
| 01/21/2009 | EP2017283A1 Peptide |
| 01/21/2009 | EP2016950A1 Pharmaceutical composition comprising an exedin-4 peptide |
| 01/21/2009 | EP2015726A1 Cosmetic composition for stimulating the synthesis of proteins of the basement membrane |
| 01/21/2009 | EP1517915B1 Prodrugs of excitatory amino acids |
| 01/21/2009 | EP1421106B1 Catalysis of the cis/trans isomerisation of secondary amide peptide compounds |
| 01/21/2009 | EP1019438B1 Apoptosis-related compounds and their use |
| 01/21/2009 | EP1007546B1 Molecular mimetics of meningococcal b epitopes |
| 01/21/2009 | EP0951466B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/21/2009 | CN100453553C Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/21/2009 | CN100453552C Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 01/20/2009 | US7479537 Reagents and methods useful for detecting diseases of the breast |
| 01/20/2009 | US7479478 Human parathyroid hormone modifications, preparation and use |
| 01/20/2009 | US7479372 Beta-secretase substrates and uses thereof |
| 01/20/2009 | CA2502856C Intermediates for retroviral protease inhibiting compounds |
| 01/20/2009 | CA2415438C .alpha. crystalline form of perindopril tert-butylamine salt |
| 01/20/2009 | CA2396678C Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 01/15/2009 | WO2009009378A2 Cathepsin-d neuroprotection |
| 01/15/2009 | US20090017522 proteolytic fragment of a growth differentiation factor (GDF) polypeptide (pro-GDF) or a functional peptide portion thereof; affects activity associated with GDF signal transduction |
| 01/15/2009 | US20090017073 Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof |
| 01/14/2009 | EP2013195A1 Gem-difluoride c-glycopeptide compounds, their preparation and use particularly for preservation of biological materials. |
| 01/14/2009 | EP2012810A2 Solid support reagents for synthesis |
| 01/14/2009 | EP1377305B1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis |
| 01/14/2009 | EP0948539B1 Peptides and compounds that bind to a receptor |
| 01/13/2009 | US7476754 Biphenyl derived thiamides as calpain inhibitors |
| 01/13/2009 | US7476721 Modified cytokines for use in cancer therapy |
| 01/13/2009 | US7476719 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof |
| 01/13/2009 | US7476657 Appear to function at least in part by inhibiting G2 cell cycle checkpoint; useful in treating metastatic and non-metastatic solid or liquid tumors |
| 01/13/2009 | US7476653 Using growth hormone secretagague receptors; endocrime disorders; gastrointestinal disorders; cardiovascular disorders; central nervous system disorders; antiproliferative agents; antiinflammatory agents |
| 01/13/2009 | US7476650 Enzyme inhibition |
| 01/08/2009 | WO2009006246A1 Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome |
| 01/08/2009 | WO2009005871A2 Novel optical labeling molecules in proteomics and other biological analyses |
| 01/08/2009 | WO2009005152A1 Novel lipid-tripeptide based hydrogel-forming agent and hydrogel |
| 01/08/2009 | WO2009005151A1 Novel lipid peptide and hydrogel |
| 01/08/2009 | WO2009003284A1 Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| 01/08/2009 | WO2009003283A1 Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| 01/08/2009 | WO2008141010A3 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| 01/08/2009 | WO2008138620A3 1-aminocyclopentane-1,3,4-tricarboxylic acids derivatives |
| 01/08/2009 | WO2007018894A3 A kit of lyophilized thrombin and lyophilized fibrinogen used to compound fibrin membrane, and its application |
| 01/08/2009 | US20090012264 Microwave-Assisted Peptide Synthesis |
| 01/08/2009 | US20090012263 Process for Production of (1,3-Disubstituted Indolyl)-Urea Derivatives, Intermediates Therefor, and Process for Production of the Intermediates |
| 01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
| 01/08/2009 | US20090012006 Par-2 Antagonists |
| 01/08/2009 | US20090011997 Bifunctional hormone and uses thereof |
| 01/08/2009 | DE102005054700B4 Neue duale Peptidase-Inhibitoren als Prodrugs zur Therapie von entzündlichen und anderen Erkrankungen New dual peptidase inhibitors as prodrugs for the treatment of inflammatory and other diseases |
| 01/08/2009 | CA2720991A1 Novel optical labeling molecules in proteomics and other biological analyses |
| 01/08/2009 | CA2692190A1 Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| 01/07/2009 | EP2011800A2 Inhibitors of caspase |
| 01/07/2009 | EP2010203A2 Macrocyclic peptides and methods for making and using them |
| 01/07/2009 | EP2010202A2 Novel antibacterial compounds |
| 01/07/2009 | EP1740600A4 Intracellular delivery of osteoinductive proteins and peptides |
| 01/07/2009 | EP1333024B1 Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 01/07/2009 | EP1115874B1 Alzheimer's disease secretase |
| 01/07/2009 | CN101338305A Process for extracting superoxide dismutase and reduction glutathion from animal blood |
| 01/07/2009 | CN100448891C Peptides and related molecules that bind to TALL-1 |
| 01/07/2009 | CN100448889C Cytotoxic depsipeptides |
| 01/05/2009 | CA2593020A1 Medicament compounds |
| 01/01/2009 | US20090005881 Composite Material Useful as Biomaterial and Its Preparation |
| 01/01/2009 | US20090005317 Methods for treating a corneal disorder and promoting skin wound healing |
| 12/31/2008 | WO2009002203A1 Polyfunctional fullerene c60 aminoacid derivatives |
| 12/31/2008 | WO2009000077A1 Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof |
| 12/31/2008 | WO2008141012A3 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof |
| 12/31/2008 | WO2008140782A3 Compounds for enzyme inhibition |
| 12/31/2008 | WO2008060552A3 Synthetic peptide amides and dimers thereof |
| 12/31/2008 | WO2007084631A3 Translocation and mutant ros kinase in human non-small cell lung carcinoma |
| 12/31/2008 | EP2008664A2 Modified proteins which bind extracellular matrix components |
| 12/31/2008 | EP2007789A2 Hcv/hiv inhibitors and their uses |
| 12/31/2008 | EP2007788A2 Hcv inhibitors |
| 12/31/2008 | EP2007787A2 Hcv inhibitors comprising beta amino acids and their uses |
| 12/31/2008 | EP1648923B1 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 12/31/2008 | EP1268525B1 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 12/31/2008 | EP1040119B1 Hemiasterlin analogs |
| 12/31/2008 | CN101336248A Novel compounds which interact with PEA-15 |
| 12/31/2008 | CN100447152C Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 12/31/2008 | CN100447151C Peptide boronic acids useful in making salts thereof |
| 12/31/2008 | CA2690943A1 Conjugates containing hydrophilic spacer linkers |
| 12/31/2008 | CA2687557A1 Polyfunctional fullerene c60 amino acid derivatives |
| 12/30/2008 | US7470774 Anti-pro1477 antibodies |
| 12/30/2008 | CA2226256C New thrombin inhibitors, their preparation and use |
| 12/24/2008 | WO2008157483A2 Polypeptides and methods of use |
| 12/24/2008 | WO2008154738A1 Azapeptides as cd36 binding compounds |
| 12/24/2008 | WO2008106104A3 Environmentally sensitive fluorophores |